Compass Therapeutics Ownership 2024 | Who Owns Compass Therapeutics Now?
Institutional Ownership
3.01%
Insider Ownership
12.04%
Retail Ownership
84.95%
Institutional Holders
20.00
Compass Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 16.37% | 0.44% | 22,362,850 | - | - | 22,362,850 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.15% | 0.02% | 11,130,000 | - | - | 11,130,000 | Jun 30, 2024 |
| BLACKSTONE INC. | 5.63% | 0.03% | 7,691,561 | 1,502,010 | 24.27% | 7,691,561 | Jun 30, 2024 |
| BLACKROCK INC. | 4.84% | 0.00% | 6,613,637 | 581,171 | 9.63% | 6,613,637 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 4.04% | 0.17% | 5,513,788 | - | - | 5,513,788 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 3.82% | 0.00% | 5,216,342 | -1,276,558 | -19.66% | 5,764,058 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 3.66% | 0.78% | 5,005,086 | 3,033,684 | 153.88% | 5,005,086 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.07% | 0.00% | 4,192,529 | 40,332 | 0.97% | 4,192,529 | Jun 30, 2024 |
| FMR LLC | 3.02% | 0.00% | 4,130,375 | -384,762 | -8.52% | 4,130,375 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 2.60% | 0.33% | 3,556,023 | - | - | 3,556,023 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 2.07% | 0.79% | 2,829,712 | - | - | 2,829,712 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.68% | 0.00% | 2,290,683 | 215,348 | 10.38% | 2,290,949 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 1.49% | 0.12% | 2,030,823 | -3,529,477 | -63.48% | 2,030,823 | Jun 30, 2024 |
| STATE STREET CORP | 1.36% | 0.00% | 1,860,169 | 33,992 | 1.86% | 1,860,169,000 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 1.14% | 0.02% | 1,557,630 | - | - | 1,557,630 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.55% | 0.00% | 747,564 | -19,347 | -2.52% | 747,564,000 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.37% | 0.06% | 500,000 | - | - | 500,000 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.32% | 0.00% | 433,755 | 239,988 | 123.85% | 433,755 | Jun 30, 2024 |
| CM MANAGEMENT, LLC | 0.23% | 0.28% | 310,000 | - | - | 310,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.22% | 0.00% | 304,504 | - | - | 304,504 | Jun 30, 2024 |
Compass Therapeutics's largest institutional shareholder is ORBIMED ADVISORS LLC, holding 16.37% of the company's total share outstanding, currently valued at $22.36M. The top 10 institutional shareholders own together 55.20% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLUE OWL CAPITAL HOLDINGS LP | 2.07% | 0.79% | 2,829,712 | - | - | 2,829,712 | Jun 30, 2024 |
| BIOIMPACT CAPITAL LLC | 3.66% | 0.78% | 5,005,086 | 3,033,684 | 153.88% | 5,005,086 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 16.37% | 0.44% | 22,362,850 | - | - | 22,362,850 | Jun 30, 2024 |
| VIVO CAPITAL, LLC | 2.60% | 0.33% | 3,556,023 | - | - | 3,556,023 | Jun 30, 2024 |
| CM MANAGEMENT, LLC | 0.23% | 0.28% | 310,000 | - | - | 310,000 | Jun 30, 2024 |
| CAXTON CORP | 0.03% | 0.22% | 43,465 | - | - | 43,465 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 4.04% | 0.17% | 5,513,788 | - | - | 5,513,788 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 1.49% | 0.12% | 2,030,823 | -3,529,477 | -63.48% | 2,030,823 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.09% | 0.10% | 124,394 | 124,394 | 100.00% | 124,394 | Jun 30, 2024 |
| MONASHEE INVESTMENT MANAGEMENT LLC | 0.37% | 0.06% | 500,000 | - | - | 500,000 | Jun 30, 2024 |
| PENNANT INVESTORS, LP | 0.15% | 0.05% | 199,000 | - | - | 199,000 | Jun 30, 2024 |
| BLACKSTONE INC. | 5.63% | 0.03% | 7,691,561 | 1,502,010 | 24.27% | 7,691,561 | Jun 30, 2024 |
| DAFNA CAPITAL MANAGEMENT LLC | 0.09% | 0.03% | 116,882 | - | - | 116,882 | Jun 30, 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 8.15% | 0.02% | 11,130,000 | - | - | 11,130,000 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 1.14% | 0.02% | 1,557,630 | - | - | 1,557,630 | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | 0.06% | 0.01% | 82,777 | -43,191 | -34.29% | 82,777 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.05% | 0.00% | 65,922 | 65,922 | 100.00% | 66,000 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.00% | 51,233 | 51,233 | 100.00% | 51,000 | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 3.82% | 0.00% | 5,216,342 | -1,276,558 | -19.66% | 5,764,058 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.08% | 0.00% | 112,020 | -34,854 | -23.73% | 112,020 | Jun 30, 2024 |
The largest Compass Therapeutics shareholder by % of total assets is BLUE OWL CAPITAL HOLDINGS LP. The company owns 2.83M shares of Compass Therapeutics (CMPX), representing 0.79% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BIOIMPACT CAPITAL LLC | 3.66% | 0.78% | 5,005,086 | 3,033,684 | 153.88% | 5,005,086 | Jun 30, 2024 |
| BLACKSTONE INC. | 5.63% | 0.03% | 7,691,561 | 1,502,010 | 24.27% | 7,691,561 | Jun 30, 2024 |
| BLACKROCK INC. | 4.84% | 0.00% | 6,613,637 | 581,171 | 9.63% | 6,613,637 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.32% | 0.00% | 433,755 | 239,988 | 123.85% | 433,755 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.68% | 0.00% | 2,290,683 | 215,348 | 10.38% | 2,290,949 | Jun 30, 2024 |
| GROUND SWELL CAPITAL, LLC | 0.09% | 0.10% | 124,394 | 124,394 | 100.00% | 124,394 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.09% | 0.00% | 122,038 | 122,038 | 100.00% | 122,000 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.17% | - | 235,506 | 112,794 | 91.92% | 235,506 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.16% | 0.00% | 215,050 | 73,408 | 51.83% | 215,050 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.10% | 0.00% | 140,600 | 70,200 | 99.72% | 140,600 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.05% | 0.00% | 68,268 | 68,268 | 100.00% | 68,268 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.05% | 0.00% | 65,922 | 65,922 | 100.00% | 66,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 54,868 | 54,868 | 100.00% | 54,868 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | 0.04% | 0.00% | 51,233 | 51,233 | 100.00% | 51,000 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.04% | - | 50,000 | 50,000 | 100.00% | 50,000 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.21% | 0.00% | 286,191 | 45,996 | 19.15% | 286,191 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 45,556 | 45,556 | 100.00% | 45,556 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 46,017 | 45,220 | 5673.78% | 46,017 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.06% | - | 86,164 | 43,476 | 101.85% | 86,164 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.03% | 0.00% | 40,701 | 40,701 | 100.00% | 40,701 | Jun 30, 2024 |
As of Jun 30 2024, Compass Therapeutics's largest institutional buyer is BIOIMPACT CAPITAL LLC. The company purchased 3.03M stocks of CMPX, valued at $5.01M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 1.49% | 0.12% | 2,030,823 | -3,529,477 | -63.48% | 2,030,823 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | - | - | - | -3,170,000 | -100.00% | - | Jun 30, 2024 |
| JANUS HENDERSON GROUP PLC | 3.82% | 0.00% | 5,216,342 | -1,276,558 | -19.66% | 5,764,058 | Jun 30, 2024 |
| FMR LLC | 3.02% | 0.00% | 4,130,375 | -384,762 | -8.52% | 4,130,375 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.18% | - | 243,650 | -76,971 | -24.01% | 243,650 | Jun 30, 2024 |
| UBS GROUP AG | 0.04% | - | 50,228 | -59,983 | -54.43% | 50,228 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -44,974 | -100.00% | - | Jun 30, 2024 |
| PALE FIRE CAPITAL SE | 0.06% | 0.01% | 82,777 | -43,191 | -34.29% | 82,777 | Jun 30, 2024 |
| SIMPLICITY WEALTH,LLC | - | - | - | -40,243 | -100.00% | - | Jun 30, 2024 |
| BLEAKLEY FINANCIAL GROUP, LLC | - | - | - | -40,243 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -38,386 | -100.00% | - | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.08% | 0.00% | 112,020 | -34,854 | -23.73% | 112,020 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.02% | 0.00% | 24,377 | -26,153 | -51.76% | 24,377 | Jun 30, 2024 |
| NEW CAPITAL MANAGEMENT LP | - | - | - | -21,131 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.55% | 0.00% | 747,564 | -19,347 | -2.52% | 747,564,000 | Jun 30, 2024 |
| BARCLAYS PLC | 0.04% | - | 57,631 | -18,282 | -24.08% | 57,000 | Jun 30, 2024 |
| NORDEN GROUP LLC | - | - | - | -10,640 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -10,206 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 0.17% | 0.00% | 231,525 | -9,275 | -3.85% | 231,525 | Jun 30, 2024 |
| INVESCO LTD. | 0.03% | - | 37,402 | -4,361 | -10.44% | 37,402 | Jun 30, 2024 |
As of Jun 30 2024, Compass Therapeutics's biggest institutional seller is CORMORANT ASSET MANAGEMENT, LP. The company sold -3.53M shares of CMPX, valued at $2.03M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GROUND SWELL CAPITAL, LLC | 0.09% | 0.10% | 124,394 | 124,394 | 100.00% | 124,394 | Jun 30, 2024 |
| HRT FINANCIAL LP | 0.09% | 0.00% | 122,038 | 122,038 | 100.00% | 122,000 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.05% | 0.00% | 68,268 | 68,268 | 100.00% | 68,268 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.05% | 0.00% | 65,922 | 65,922 | 100.00% | 66,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 54,868 | 54,868 | 100.00% | 54,868 | Jun 30, 2024 |
| LPL FINANCIAL LLC | 0.04% | - | 50,000 | 50,000 | 100.00% | 50,000 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.03% | 0.00% | 45,556 | 45,556 | 100.00% | 45,556 | Jun 30, 2024 |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 0.03% | 0.00% | 40,701 | 40,701 | 100.00% | 40,701 | Jun 30, 2024 |
| TOWNSQUARE CAPITAL LLC | 0.01% | 0.00% | 19,195 | 19,195 | 100.00% | 19,195 | Jun 30, 2024 |
| POINT72 (DIFC) LTD | 0.01% | 0.00% | 8,231 | 8,231 | 100.00% | 8,231 | Jun 30, 2024 |
| HARTFORD FINANCIAL MANAGEMENT INC. | 0.00% | 0.00% | 1,000 | 1,000 | 100.00% | 1,000 | Jun 30, 2024 |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 0.00% | 0.00% | 391 | 391 | 100.00% | 391 | Jun 30, 2024 |
Compass Therapeutics's largest new institutional shareholder by number of shares is GROUND SWELL CAPITAL, LLC, purchased 124.39K shares, valued at $124.39K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| OPALEYE MANAGEMENT INC. | - | - | - | -3,170,000 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -44,974 | -100.00% | - | Jun 30, 2024 |
| SIMPLICITY WEALTH,LLC | - | - | - | -40,243 | -100.00% | - | Jun 30, 2024 |
| BLEAKLEY FINANCIAL GROUP, LLC | - | - | - | -40,243 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -38,386 | -100.00% | - | Jun 30, 2024 |
| NEW CAPITAL MANAGEMENT LP | - | - | - | -21,131 | -100.00% | - | Jun 30, 2024 |
| NORDEN GROUP LLC | - | - | - | -10,640 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | - | - | - | -10,206 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -1,926 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -16 | -100.00% | - | Jun 30, 2024 |
Compass Therapeutics's largest sold out institutional shareholder by shares sold is OPALEYE MANAGEMENT INC., sold -3.17M shares, valued at -, as of undefined.
Compass Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ALGER FUNDS | 0.18% | 174,563 | - | - | Jan 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 38,900 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.03% | 7,441 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.03% | 172,862 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 14,159 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 99,196 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 3,567,375 | -1,305,851 | -26.80% | Mar 31, 2024 |
| ALPS ETF Trust | 0.01% | 90,033 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 428,436 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.01% | 246,012 | -17,264 | -6.56% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 923,734 | 48,729 | 5.57% | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 77,442 | 12,412 | 19.09% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 7,536 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 39,461 | - | - | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 51,820 | -3,393 | -6.15% | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 32,198 | -7,358 | -18.60% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,701 | -1,517 | -29.07% | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,591 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 28,100 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 42,412 | 1,525 | 3.73% | Mar 28, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 5,920 | 700 | 13.41% | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 935,091 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 833 | - | - | Dec 31, 2023 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 398,915 | 36,598 | 10.10% | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 3,260,004 | -138,744 | -4.08% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 173,107 | -1,121 | -0.64% | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 27,317 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 35,021 | -142 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 3,500 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 15,091 | -78 | -0.51% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 413 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 13,288 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 243,293 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 709 | -59 | -7.68% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 13,369 | 1,577 | 13.37% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 10,950 | 1,986 | 22.16% | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 54 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 45,293 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 32,349 | 577 | 1.82% | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 77,400 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 3,100 | - | - | Feb 29, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 1,681 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 10,339 | -42 | -0.40% | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 38,386 | 866 | 2.31% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 64,966 | -2,418 | -3.59% | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 15,893 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 34,044 | -1,287 | -3.64% | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 32,748 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 1,912 | - | - | Jan 31, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 300 | 100 | 50.00% | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 16,379 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 10,922 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 698 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 11,972 | - | - | Jan 31, 2024 |
Compass Therapeutics's largest mutual fund holder by % of total assets is "ALGER FUNDS", owning 174.56K shares, compromising 0.18% of its total assets.
Compass Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 20 | -74.36% |
| 31 Mar, 24 | 78 | 2.63% |
| 31 Dec, 23 | 76 | - |
| 30 Sep, 23 | 76 | 5.56% |
| 30 Jun, 23 | 72 | -1.37% |
| 31 Mar, 23 | 73 | 32.73% |
| 31 Dec, 22 | 55 | 48.65% |
| 30 Sep, 22 | 37 | 12.12% |
| 30 Jun, 22 | 33 | - |
| 31 Mar, 22 | 33 | -10.81% |
| 31 Dec, 21 | 37 | - |
As of 30 Jun 24, 20 institutions are holding Compass Therapeutics's shares, representing a decrease of -74.36% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 4,113,966 | -95.65% |
| 31 Mar, 24 | 94,562,990 | 9.81% |
| 31 Dec, 23 | 86,111,899 | -4.02% |
| 30 Sep, 23 | 89,720,729 | -0.84% |
| 30 Jun, 23 | 90,478,972 | 10.99% |
| 31 Mar, 23 | 81,517,155 | 2.11% |
| 31 Dec, 22 | 79,833,367 | 25.01% |
| 30 Sep, 22 | 63,859,093 | 3.18% |
| 30 Jun, 22 | 61,893,457 | -0.77% |
| 31 Mar, 22 | 62,376,229 | -1.87% |
| 31 Dec, 21 | 63,567,962 | - |
Compass Therapeutics (CMPX) has 4.11M shares outstanding as of 30 Jun 24, down -95.65% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 3.01% | 0.05% |
| 31 Mar, 24 | 74.21% | 1.62% |
| 31 Dec, 23 | 67.58% | 1.35% |
| 30 Sep, 23 | 70.80% | 1.38% |
| 30 Jun, 23 | 71.60% | 1.72% |
| 31 Mar, 23 | 64.50% | 1.12% |
| 31 Dec, 22 | 75.90% | 1.90% |
| 30 Sep, 22 | 63.22% | 1.68% |
| 30 Jun, 22 | 61.31% | 1.60% |
| 31 Mar, 22 | 61.85% | 0.41% |
| 31 Dec, 21 | 122.45% | - |
As of 30 Jun 24, Compass Therapeutics is held by 3.01% institutional shareholders, representing a 0.05% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 14 | -48.15% |
| 31 Mar, 24 | 27 | -20.59% |
| 31 Dec, 23 | 34 | -10.53% |
| 30 Sep, 23 | 38 | -13.64% |
| 30 Jun, 23 | 44 | -13.73% |
| 31 Mar, 23 | 51 | 18.60% |
| 31 Dec, 22 | 43 | 115.00% |
| 30 Sep, 22 | 20 | 81.82% |
| 30 Jun, 22 | 11 | -8.33% |
| 31 Mar, 22 | 12 | -67.57% |
| 31 Dec, 21 | 37 | - |
14 institutional shareholders have increased their position in CMPX stock as of 30 Jun 24 compared to 27 in the previous quarter (a -48.15% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 2 | -94.29% |
| 31 Mar, 24 | 35 | 40.00% |
| 31 Dec, 23 | 25 | 31.58% |
| 30 Sep, 23 | 19 | 5.56% |
| 30 Jun, 23 | 18 | 63.64% |
| 31 Mar, 23 | 11 | 175.00% |
| 31 Dec, 22 | 4 | 33.33% |
| 30 Sep, 22 | 3 | -62.50% |
| 30 Jun, 22 | 8 | 60.00% |
| 31 Mar, 22 | 5 | - |
| 31 Dec, 21 | - | - |
2 institutional shareholders have reduced their position in CMPX stock as of 30 Jun 24 compared to 35 in the previous quarter (a -94.29% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 20 | -74.36% | 4,113,966 | -95.65% | 3.01% | 0.05% | 14 | -48.15% | 2 | -94.29% |
| 31 Mar, 24 | 78 | 2.63% | 94,562,990 | 9.81% | 74.21% | 1.62% | 27 | -20.59% | 35 | 40.00% |
| 31 Dec, 23 | 76 | - | 86,111,899 | -4.02% | 67.58% | 1.35% | 34 | -10.53% | 25 | 31.58% |
| 30 Sep, 23 | 76 | 5.56% | 89,720,729 | -0.84% | 70.80% | 1.38% | 38 | -13.64% | 19 | 5.56% |
| 30 Jun, 23 | 72 | -1.37% | 90,478,972 | 10.99% | 71.60% | 1.72% | 44 | -13.73% | 18 | 63.64% |
| 31 Mar, 23 | 73 | 32.73% | 81,517,155 | 2.11% | 64.50% | 1.12% | 51 | 18.60% | 11 | 175.00% |
| 31 Dec, 22 | 55 | 48.65% | 79,833,367 | 25.01% | 75.90% | 1.90% | 43 | 115.00% | 4 | 33.33% |
| 30 Sep, 22 | 37 | 12.12% | 63,859,093 | 3.18% | 63.22% | 1.68% | 20 | 81.82% | 3 | -62.50% |
| 30 Jun, 22 | 33 | - | 61,893,457 | -0.77% | 61.31% | 1.60% | 11 | -8.33% | 8 | 60.00% |
| 31 Mar, 22 | 33 | -10.81% | 62,376,229 | -1.87% | 61.85% | 0.41% | 12 | -67.57% | 5 | - |
| 31 Dec, 21 | 37 | - | 63,567,962 | - | 122.45% | - | 37 | - | - | - |
Compass Therapeutics Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Compass Therapeutics's stock was made by Anderman Jonathan on Aug 09 2024, selling - shares at - per share (valued at -).
Compass Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | 6 | 16.67% |
| Q1 2024 | 10 | 2 | 500.00% |
| Q4 2023 | - | 2 | - |
| Q2 2023 | 1 | - | - |
| Q1 2023 | 14 | - | - |
| Q4 2022 | 2 | 3 | 66.67% |
| Q3 2022 | 5 | - | - |
| Q2 2022 | 27 | 2 | 1350.00% |
| Q1 2022 | 10 | - | - |
| Q4 2021 | 6 | - | - |
| Q2 2021 | 3 | 1 | 300.00% |
| Q1 2021 | 2 | - | - |
| Q4 2020 | 1 | - | - |
| Q3 2020 | 4 | - | - |
| Q2 2020 | 6 | 5 | 120.00% |
| Q3 2018 | - | 2 | - |
| Q1 2006 | 2 | 10 | 20.00% |
| Q4 2005 | 1 | 1 | 100.00% |
| Q2 2005 | 3 | - | - |
| Q4 2004 | 2 | - | - |
1 total buy trades, and 6 total sell trades (buy/sell ratio of 0.17%) were made by Compass Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | 5 | - | - |
| Q4 2022 | 2 | 3 | 66.67% |
| Q3 2022 | 5 | - | - |
| Q2 2022 | 23 | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 4 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 6 | - | - |
| Q3 2018 | - | - | - |
| Q1 2006 | - | - | - |
| Q4 2005 | - | - | - |
| Q2 2005 | 3 | - | - |
| Q4 2004 | 1 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Compass Therapeutics's stocks.
Compass Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ANAB | AnaptysBio, Inc. |
| VIGL | Vigil Neuroscience, Inc. |
| GOSS | Gossamer Bio, Inc. |
| IDYA | IDEAYA Biosciences, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| IVA | Inventiva S.A. |
| PRTC | PureTech Health plc |
| MGTX | MeiraGTx Holdings plc |
| AVTE | Aerovate Therapeutics, Inc. |
| REPL | Replimune Group, Inc. |
| TYRA | Tyra Biosciences, Inc. |
| KRON | Kronos Bio, Inc. |
| KROS | Keros Therapeutics, Inc. |
| MLTX | MoonLake Immunotherapeutics |
| GLUE | Monte Rosa Therapeutics, Inc. |
| GPCR | Structure Therapeutics Inc. |
| NAMS | NewAmsterdam Pharma Company N.V. |
| PEPG | PepGen Inc. |
| FIXX | Q32 Bio Inc. |
| LYRA | Lyra Therapeutics, Inc. |
| NVCT | Nuvectis Pharma, Inc. |
| ELVN | Enliven Therapeutics, Inc. |
CMPX Ownership FAQ
Who Owns Compass Therapeutics?
Compass Therapeutics is owned by institutional shareholders (3.01%), insiders (12.04%), and public (84.95%). The largest institutional shareholder of Compass Therapeutics is ORBIMED ADVISORS LLC (16.37% of total shares) and the top mutual fund owner is ALGER FUNDS (0.18% of total shares).
Who are the major institutional shareholders of Compass Therapeutics?
Compass Therapeutics's major institutional shareholders are ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BLACKSTONE INC., BLACKROCK INC., and ROCK SPRINGS CAPITAL MANAGEMENT LP. The top five shareholders own together 39.03% of the company's share outstanding.
How many Compass Therapeutics shareholders are there?
As of Jun 2024, there are 20 institutional shareholders of Compass Therapeutics.
What percentage of Compass Therapeutics is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC owns 22.36M shares of Compass Therapeutics, representing 16.37% of the company's total shares outstanding, valued at $22.36M (as of Jun 2024).
What percentage of Compass Therapeutics is owned by ADAGE CAPITAL PARTNERS GP, L.L.C?
As of Jun 2024, ADAGE CAPITAL PARTNERS GP, L.L.C holds 11.13M shares of Compass Therapeutics (CMPX), compromising 8.15% of the company, valued at $11.13M.
What percentage of Compass Therapeutics is owned by BLACKSTONE INC?
BLACKSTONE INC is the third largest holder of Compass Therapeutics. The company owns 7.69M of the company's shares outstanding (worth $7.69M).